Drug Shortage Report for RECOMBIVAX HB

Last updated on 2020-02-13 History
Report ID 873
Drug Identification Number 02243676
Brand name RECOMBIVAX HB -(PRESERVATIVE FREE)
Common or Proper name (hepatitis B vaccine [recombinant])
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 10MCG/1ML 10X1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-08-01
Actual start date 2017-08-04
Estimated end date 2021-03-01
Actual end date
Shortage status Actual shortage
Updated date 2020-02-13
Company comments Recombivax (Adult presentation): Anticipated end date of the shortage - March 2021 (tbc).
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v36 2020-02-13 French Compare
v35 2020-02-13 English Compare
v34 2019-07-04 French Compare
v33 2019-07-04 English Compare
v32 2018-12-11 English Compare
v31 2018-05-30 English Compare
v30 2017-10-03 English Compare
v29 2017-09-26 French Compare
v28 2017-09-26 English Compare
v27 2017-09-21 English Compare
v26 2017-09-21 French Compare
v25 2017-09-21 French Compare
v24 2017-09-21 English Compare
v23 2017-08-07 French Compare
v22 2017-08-07 English Compare
v21 2017-08-06 French Compare
v20 2017-08-06 English Compare
v19 2017-08-06 English Compare
v18 2017-08-02 English Compare
v17 2017-08-02 English Compare

Showing 1 to 20 of 36